Work

Activity of targeted therapy after failure of first-line immunotherapy in BRAF-mutant metastatic melanoma.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.9532

Authors: Cathy Yi Xia, Daniel Ying Wang, Robert Mason, Jessica Louise Smith, Meredith Ann McKean, Serigne Lo, Alexander David Guminski, Georgina V. Long, Matteo S. Carlino, Victoria Atkinson, Michael Millward, Jennifer Leigh McQuade, Rodabe Navroze Amaria, Douglas Buckner Johnson, Alexander M. Menzies

Institutions: Melanoma Institute Australia, Vanderbilt University Medical Center, The University of Queensland, Princess Alexandra Hospital, Westmead Hospital, The University of Texas MD Anderson Cancer Center, The University of Sydney, Royal North Shore Hospital

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891612954

Cites:

Cited by: 15

Related to: 10